Sensei Biotherapeutics, Inc. (SNSE)
17.19
-2.72
(-13.66%)
USD |
NASDAQ |
May 19, 13:04
Sensei Biotherapeutics Total Liabilities (Quarterly) : 4.582M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| KalVista Pharmaceuticals, Inc. | 348.57M |
| Oncolytics Biotech, Inc. | 13.29M |
| Vir Biotechnology, Inc. | 212.82M |
| Recursion Pharmaceuticals, Inc. | 314.75M |
| Acurx Pharmaceuticals, Inc. | 2.527M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 27.59M |
| Shareholders Equity (Quarterly) | 23.01M |
| Debt to Equity Ratio | 0.0878 |
| Current Ratio | 5.813 |
| Net Debt Paydown Yield | 5.08% |